CCL2 and Alzheimer disease: A meta-analysis report showed consistently elevated levels of inflammatory biomarkers such as C-reactive protein, IL-1β, IL-2, IL-6, IL-12, IL-18, MCP-1, MCP-3, IL-8, and IP-10 in AD but inconsistent results for MCI other than elevated levels of MCP-1 [43].